AbbVie Inc.

$ABBV with a Neutral outlook following its earnings #Stocks

27
The PEAD projected a Neutral outlook for ABBV after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.